Kintara Therapeutics Inc (KTRA): This will cup back up to the 1.50s.. no...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	195
Boards Moderated	0
Alias Born	11/11/2016

Maknmoney78

Re: None

Wednesday, 10/13/2021 9:43:41 AM

Wednesday, October 13, 2021 9:43:41 AM

This will cup back up to the 1.50s.. no reason for the recent fall in price .. it was trading there mid September .. technicals are perfect for the continued uptrend

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent KTRA News

Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/17/2024 08:10:11 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/17/2024 08:05:37 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/14/2024 08:55:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:50:14 PM
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results • PR Newswire (US) • 05/14/2024 08:45:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:40:36 PM
Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 05/13/2024 08:06:50 PM
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm • PR Newswire (US) • 04/05/2024 05:09:00 PM
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement • PR Newswire (US) • 04/03/2024 11:00:00 AM
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab • PR Newswire (US) • 03/27/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:59:49 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:00:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:00:10 PM
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 02/14/2024 09:07:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:05:27 PM
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer • PR Newswire (US) • 02/12/2024 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:10:10 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/18/2023 09:05:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:15:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 02:10:19 PM
Kintara Therapeutics Announces Review of Strategic Alternatives • PR Newswire (US) • 12/07/2023 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 02:10:08 PM
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement • PR Newswire (US) • 12/05/2023 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 12:55:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:23 PM

More KTRA News

InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover